Urinary Prothrombin Fragment 1+2 in relation to Development of Non-Symptomatic and Symptomatic Venous Thromboembolic Events following Total Knee Replacement

Por Borris, Lars C., Breindahl, Morten, Lassen, Michael R., Pap, Ákos F.
Publicado em 2011

Letter to the Editor: Potent Anticoagulants Are Associated with a Higher All-cause Mortality Rate After Hip and Knee Arthroplasty

Por Eriksson, Bengt I., Friedman, Richard J., Cushner, Fred D., Lassen, Michael R.
Publicado em 2008

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery

Por Turpie, Alexander GG, Schmidt, André C, Kreutz, Reinhold, Lassen, Michael R, Jamal, Waheed, Mantovani, Lorenzo, Haas, Sylvia
Publicado em 2012

Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co‐medication interactions

Por Kreutz, Reinhold, Haas, Sylvia, Holberg, Gerlind, Lassen, Michael R., Mantovani, Lorenzo G., Schmidt, André, Turpie, Alexander G. G.
Publicado no Br J Clin Pharmacol (2016)

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial

Por Cohen, Alexander T, Davidson, Bruce L, Gallus, Alexander S, Lassen, Michael R, Prins, Martin H, Tomkowski, Witold, Turpie, Alexander G G, Egberts, Jan F M, Lensing, Anthonie W A
Publicado em 2006